Boehringer Ingelheim Gmbh

Boehringer Ingelheim Vetmedica Gmbh

Dr. Karl Thomae Gmbh

Other

Karl Thomae Gmbh

Dr. Karl Thomae Gesellschaft MIT Beschrankter Haftung

Gunther Engelhardt

Wolfhard Engel

Ernst Seeger

Gunter Trummlitz

Gunther Schmidt

Helmut Pieper

Rainer Zimmermann

Helmut Teufel

Wolfgang Eberlein

Johannes Keck

Wolfgang Resemann

Adolf Durr

John F Quirke

Josef Nickl

Walter Haarmann

Klaus Reinhold Noll

Matyas Leitold

Gerd Kruger

Oswald Tauber

Sigfrid Puschmann

Klaus Rudolf

Armin Heckel

Erich Muller

Gerhard Mihm

Norbert Mayer

Klaus-Reinhold Noll

Josef Nickl, Deceased

Willy Roth

Helmut Ballhause

Kruger

Norbert Promberger

Claus A Landgraf

Kurt Schumacher

Alex Prox

The invention relates to the separation of enantiomers of cimaterol, (-)-cimaterol, the addition salts thereof and processes for preparing them and their use in pharmaceutical compositions and animal feeds.

Separation of enantiomers of cimaterol, (-)-cimaterol and the use

Pharmaceutical compositions are described which contain 1,5,6,7-tetrahydro-4H-indazol-4-ones of the formula ##STR1## some of these substances themselves being new. The pharmaceutical compositions may be used as analgesics, antipyretics and antiphlogistics.

1,5,6,7-tetrahydro-4H-indazol-4-ones

The invention relates to phenylethanolamines of general formula ##STR1## wherein R.sub.1 and R.sub.2 are defined as in claim 1, the enantiomers and the acid addition salts thereof, which have valuable pharmacological properties, not only analgesic, antiphlogistic, broncholytic, uterus-spasmolytic, lipolytic effects and an antispastic effect on the cross-striped muscle, but also .beta..sub.2 -mimetic and/or .beta..sub.1 -blocking effects, the use thereof as pharmaceuticals and as performance enhancers and processes for preparing them.

Phenylethanolamines, pharmaceutical compositions containing these

The invention relates to the separation of enantiomers, of cimaterol, (-)-cimaterol, the addition salts thereof and processes for preparing them and their use in pharmaceutical compositions and animal feeds.

Novel compounds of the general formula ##STR1## which have antitussive activity, wherein R.sub.1 -R.sub.4 are as defined herein.

Substituted 6-benzyl-2H-3,4,5,6-tetrahydro-(1,3)-oxazines

This invention relates to pharmaceutical compositions containing quinolin-2,5-diones of formula ##STR1## wherein A, B, R.sup.1 to R.sup.3 and X are defined hereinbelow, some of which are novel, which compounds have valuable pharmacological properties, particularly analgesic antipyretic and/or antiphlogistic effects, to new intermediates and processes for preparing them.

Pharmaceutical compositions containing quinolin-2,5-diones, new

This invention is directed to the compounds of the formula ##STR1## wherein R.sub.1 is hydrogen or an alkyl of from 1 to 6 carbon atoms;

1,4,9,10-Tetrahydro-pyrazolo [4,3-]pyrido[-3,2-b][1,4]diazepin-10-ones

Compounds of the formula ##STR1## wherein each X, which may be identical or different from the other X, is oxygen or imino;

Esters and amides containing the

Analgesic and antipyretic pharmaceutical dosage unit compositions containing as an active ingredient a compound of the formula ##STR1## wherein R.sub.5 is methyl or methoxy, and R.sub.4, R.sub.6 and R.sub.7 are hydrogen; or

Analgesic and antipyretic pharmaceutical compositions containing a

There are described pharmaceutical compositions containing as active substances benzothiazol-2(3H)-ones of the general formula ##STR1## wherein R represents a hydrogen atom or a methyl, methoxy, or ethoxy group. The pharmaceutical compositions serve as analgesics and antipyretics and possess little or no methemoglobin-forming activity.

Suppressing pain with benzothiazol-2(3H)-ones

Pharmaceutical compositions containing a non-steroidal anti-inflammatory compound and 5,11-dihydro-11-[(4-methyl-1-piperazinyl)-acetyl]-6H-pyrido[2,3-b]-[1,4]be nzodiazepin-6-one or a non-toxic acid addition salt thereof, and a method of using the same as antiphlogistics; the pyridobenzodiazepinone ingredient effectively suppresses the gastro-intestinal side-effects of the anti-inflammatory ingredient.

Antiphlogistic pharmaceutical compositions and method of use

Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen, halogen or alkyl of 1 to 3 carbon atoms; R.sub.2 is hydrogen or alkyl of 1 to 3 carbon atoms; and

4-Hydroxy-2H-[1]-benzothieno

Growing community of inventors

Biberach, Germany

Gunther Engelhardt